INTELLIA THERAPEUTICS INC (NTLA) Stock Analyst Earnings Estimates
NASDAQ:NTLA - Nasdaq - US45826J1051 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 33.05M -43.01% | 52.12M 57.70% | 36.275M -30.40% | 54.659M 50.68% | 54.157M -0.92% | 42.771M -21.02% | 486.83M 1,038.22% | 1.178B 141.97% | 2.514B 113.41% | 3.683B 46.50% | 2.355B -36.06% | 2.82B 19.75% | |
| EBITDA YoY % growth | -260.96M -100.32% | -450.59M -72.67% | -506.315M -12.37% | -529.463M -4.57% | -590.338M -11.50% | -638.449M -8.15% | 252.96M 139.62% | 656.88M 159.68% | 1.033B 57.26% | 1.246B 20.62% | 1.357B 8.91% | N/A | |
| EBIT YoY % growth | -267.85M -96.11% | -458.16M -71.05% | -515.291M -12.47% | -548.719M -6.49% | -575.081M -4.80% | -626.545M -8.95% | -344.68M 44.99% | 116.44M 133.78% | 926.01M 695.27% | 1.627B 75.70% | 870.45M -46.50% | 1.146B 31.66% | |
| Operating Margin | -810.44% | -879.05% | -1,420.51% | -1,003.89% | -1,061.88% | -1,464.88% | -70.80% | 9.88% | 36.83% | 44.18% | 36.96% | 40.64% | |
| EPS YoY % growth | -3.76 -56.67% | -6.18 -64.36% | -5.41 12.46% | -5.42 -0.26% | -5.22 3.81% | -5.31 -1.77% | -1.94 63.53% | 2.68 238.36% | 10.76 301.80% | 18.71 73.84% | 8.25 -55.93% | 10.48 27.01% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.36 7.13% | -1.38 -23.10% | -1.29 15.00% | -1.29 3.45% | -1.27 6.22% | -1.04 24.91% | -1.09 15.92% | -1.16 10.72% | -1.23 3.42% |
| Revenue Q2Q % growth | 8.703M 553.99% | 11.073M -61.73% | 10.983M 57.87% | 11.262M 23.61% | 11.592M 33.20% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -157.335M 68.93% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -150.257M 70.84% | -146.339M -28.36% | -143.198M -2.99% | -146.904M -1.47% | -152.704M -1.63% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.34 2.90% | -1.41 | 0.07 | 5.12% |
| Q2 2024 Q2Q % growth | -1.52 -8.57% | -1.26 | -0.26 | -20.94% |
| Q1 2024 Q2Q % growth | -1.12 4.27% | -1.41 | 0.29 | 20.41% |
| Q4 2023 Q2Q % growth | -1.46 -4.29% | -1.48 | 0.02 | 1.23% |
| Q3 2023 Q2Q % growth | -1.38 7.38% | -1.53 | 0.15 | 9.73% |
| Q2 2023 Q2Q % growth | -1.40 -5.26% | -1.35 | -0.05 | -3.91% |
| Q1 2023 Q2Q % growth | -1.17 40.31% | -1.43 | 0.26 | 18.08% |
| Q4 2022 Q2Q % growth | -1.40 -28.44% | -1.42 | 0.02 | 1.45% |
| Q3 2022 Q2Q % growth | -1.49 -53.61% | -1.31 | -0.18 | -13.96% |
| Q2 2022 Q2Q % growth | -1.33 -31.68% | -1.33 | 0.00 | 0.17% |
| Q1 2022 Q2Q % growth | -1.96 -184.06% | -1.13 | -0.83 | -73.90% |
| Q4 2021 Q2Q % growth | -1.09 -57.97% | -0.96 | -0.13 | -13.14% |
| Q3 2021 Q2Q % growth | -0.97 -106.38% | -0.86 | -0.11 | -12.71% |
| Q2 2021 Q2Q % growth | -1.01 -65.57% | -0.65 | -0.36 | -56.35% |
| Q1 2021 Q2Q % growth | -0.69 -9.52% | -0.67 | -0.02 | -2.83% |
| Q4 2020 Q2Q % growth | -0.69 -21.05% | -0.61 | -0.08 | -12.32% |
| Q3 2020 Q2Q % growth | -0.47 4.08% | -0.60 | 0.13 | 21.98% |
| Q2 2020 Q2Q % growth | -0.61 -8.93% | -0.70 | 0.09 | 13.41% |
| Q1 2020 Q2Q % growth | -0.63 -28.57% | -0.43 | -0.20 | -45.52% |
| Q4 2019 Q2Q % growth | -0.57 | -0.57 | 0.00 | 0.65% |
| Q3 2019 Q2Q % growth | -0.49 | -0.63 | 0.14 | 22.37% |
| Q2 2019 Q2Q % growth | -0.56 | -0.61 | 0.05 | 8.91% |
| Q1 2019 Q2Q % growth | -0.49 | -0.60 | 0.11 | 18.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 9.111M -24.02% | 8.013M | 1.098M | 13.70% |
| Q2 2024 Q2Q % growth | 6.957M -48.82% | 19.545M | -12.588M | -64.41% |
| Q1 2024 Q2Q % growth | 28.935M 129.53% | 11.734M | 17.201M | 146.59% |
| Q4 2023 Q2Q % growth | -1.917M -114.13% | 13.082M | -14.999M | -114.65% |
| Q3 2023 Q2Q % growth | 11.992M -9.63% | 12.697M | -705K | -5.55% |
| Q2 2023 Q2Q % growth | 13.594M -3.11% | 12.319M | 1.275M | 10.35% |
| Q1 2023 Q2Q % growth | 12.606M 12.05% | 12.063M | 543K | 4.50% |
| Q4 2022 Q2Q % growth | 13.57M 5.60% | 11.558M | 2.012M | 17.41% |
| Q3 2022 Q2Q % growth | 13.27M 84.31% | 11.569M | 1.701M | 14.70% |
| Q2 2022 Q2Q % growth | 14.03M 114.20% | 9.602M | 4.428M | 46.12% |
| Q1 2022 Q2Q % growth | 11.25M 74.42% | 8.715M | 2.535M | 29.09% |
| Q4 2021 Q2Q % growth | 12.85M 94.70% | 8.426M | 4.424M | 52.50% |
| Q3 2021 Q2Q % growth | 7.2M -67.60% | 8.837M | -1.637M | -18.52% |
| Q2 2021 Q2Q % growth | 6.55M -59.72% | 12.128M | -5.578M | -45.99% |
| Q1 2021 Q2Q % growth | 6.45M -50.08% | 10.055M | -3.605M | -35.85% |
| Q4 2020 Q2Q % growth | 6.6M -39.67% | 14.377M | -7.777M | -54.09% |
| Q3 2020 Q2Q % growth | 22.22M 109.23% | 15.896M | 6.324M | 39.78% |
| Q2 2020 Q2Q % growth | 16.26M 46.22% | 8.716M | 7.544M | 86.55% |
| Q1 2020 Q2Q % growth | 12.92M 23.87% | 19.782M | -6.862M | -34.69% |
| Q4 2019 Q2Q % growth | 10.94M | 10.137M | 803K | 7.92% |
| Q3 2019 Q2Q % growth | 10.62M | 9.615M | 1.005M | 10.45% |
| Q2 2019 Q2Q % growth | 11.12M | 7.257M | 3.863M | 53.23% |
| Q1 2019 Q2Q % growth | 10.43M | 7.757M | 2.673M | 34.46% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.66% | 1.66% | -0.07% | 1.83% |
| Revenue | -5.98% | -5.98% | 0% | -0.03% |